Skip to main content
Veterinary Medicines

Miziverm, 12,5/125mg, Tablet

Authorised
  • Milbemycin oxime
  • Praziquantel

Product identification

Medicine name:
Miziverm, 12,5/125mg, Tablet
Miziverm 12.5 mg/125 mg таблетки за кучета
Active substance:
  • Milbemycin oxime
  • Praziquantel
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Milbemycin oxime
    12.50
    milligram(s)
    /
    1.00
    Tablet
  • Praziquantel
    125.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AB51
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:
  • Aluminum/Plastic Sachet 1 x 2.0 Tablet sáček- PET/Al/LDPE folie
  • Aluminum/Plastic Sachet 1 x 50.0 Tablet sáček- PET/Al/LDPE folie

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Bulgarian Food Safety Authority
Authorisation number:
  • 0022-3354
Date of authorisation status change:
Reference member state:
  • Czechia
Procedure number:
  • CZ/V/0203/002
Concerned member states:
  • Bulgaria
  • Greece
  • Hungary
  • Latvia
  • Lithuania
  • Malta
  • Poland
  • Romania
  • Slovakia
Generic of:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 10/02/2026

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 10/02/2026

Labelling

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 10/02/2026